Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Lenalidomide Maintenance after VTD Induction and Autologous Stem Cell Transplantation: An Italian Real-Life Study of 558 Patients

Blood (2023) 142 (Supplement 1): 1959.

https://doi.org/10.1182/blood-2023-179922

Published: 2023

Journal Articles

Treatment of Portal, Mesenteric, and Splenic Vein Thrombosis with Rivaroxaban: A Pilot, Prospective Cohort Study

Blood (2021) 138 (Supplement 1): 671.

https://doi.org/10.1182/blood-2021-153813

Published: 2021

Journal Articles

Risk of Recurrence after Stopping Anticoagulants in Women with Combined Oral Contraceptive-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis

Blood (2021) 138 (Supplement 1): 776.

https://doi.org/10.1182/blood-2021-147723

Published: 2021

Journal Articles

A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

Blood (2020) 136 (2): 171–182.

https://doi.org/10.1182/blood.2019004596

Published: 2020

Includes: Supplemental data

Journal Articles

Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

Blood (2018) 132 (Supplement 1): 2464.

https://doi.org/10.1182/blood-2018-99-112447

Published: 2018

Journal Articles

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Blood (2018) 132 (Supplement 1): 2465.

https://doi.org/10.1182/blood-2018-99-113996

Published: 2018

Journal Articles

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Luciano Baronciani, PhD, Flora Peyvandi, MD PhD, Anne Goodeve, PhD, Reinhard Schneppenheim, MDPhD, Zahra Badiee, Mohammad-Reza Baghaipour, Javier Battle, Erik Berntorp, MD PhD, Imre Bodó, MD PhD, Ulrich Budde, MD, Andrea Cairo, PhD, Giancarlo Castaman, Laura Crookes, Jeroen C.J. Eikenboom, MD, Peyman Eshghi, MD, Cosimo Ettorre, MD, Jenny Goudemand, MD PhD, Wolf Hassenpflug, Charles Richard Morris Hay, MDFRCP,FRCPath, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank W.G. Leebeek, MD PhD, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, MD, Maria Gabriella Mazzucconi, MD, Massimo Morfini, MD, Nikolas Nikšić, Johannes Oldenburg, Florian Oyen, Rafael Parra Lòpez, Ian Peake, PhD, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Sayed Omid Reza Zekavat, MD, Eva M.K. Zetterberg, MD PhD, Augusto B Federici, MD

Blood (2018) 132 (Supplement 1): 1184.

https://doi.org/10.1182/blood-2018-99-114702

Published: 2018

Journal Articles

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Alberto Tosetto, Pamela A Christopherson, Jeroen C.J. Eikenboom, MD, Julie Grabell, CCRP, Paula D. James, MD, Robert R Montgomery, MD, Ian Peake, PhD, Mariana Silva, MD FRCPC, Zimmerman Program Investigators

Blood (2018) 132 (Supplement 1): 1180.

https://doi.org/10.1182/blood-2018-99-115728

Published: 2018

Journal Articles

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Blood (2018) 132 (13): 1365–1371.

https://doi.org/10.1182/blood-2018-04-848333

Published: 2018

Journal Articles

How I treat type 2 variant forms of von Willebrand disease

Alberto Tosetto, Giancarlo Castaman

Blood (2015) 125 (6): 907–914.

https://doi.org/10.1182/blood-2014-08-551960

Published: 2015

Journal Articles

Safety of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study

Riva Nicoletta, Alberto Tosetto, MD, Walter Ageno, MD, Daniela Poli, MD, Sophie Testa, MD, Serena Rupoli, MD, Rita Santoro, Francesco Rodeghiero

Blood (2014) 124 (21): 4276.

https://doi.org/10.1182/blood.V124.21.4276.4276

Published: 2014

Journal Articles

D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study

Gualtiero Palareti, Benilde Cosmi, Cristina Legnani, Emilia Antonucci, Valeria De Micheli, Angelo Ghirarduzzi, Daniela Poli, Sophie Testa, Alberto Tosetto, Vittorio Pengo, Paolo Prandoni

Blood (2014) 124 (2): 196–203.

https://doi.org/10.1182/blood-2014-01-548065

Published: 2014

Journal Articles

Platelet Cut-Off For Anticoagulant Therapy In Cancer Patients With Venous Thromboembolism and Thrombocytopenia: An Expert Opinion Based On RAND/UCLA Appropriateness Method (RAM)

Giorgia Saccullo, MD, Marco Marietta, Monica Carpenedo, Valerio De Stefano, MD, Anna Falanga, Augusto B. Federici, MD, Francesco Rodeghiero, Alberto Tosetto, M.D., Sergio Siragusa, MD

Blood (2013) 122 (21): 581.

https://doi.org/10.1182/blood.V122.21.581.581

Published: 2013

Journal Articles

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

Blood (2013) 121 (14): 2596–2606.

https://doi.org/10.1182/blood-2012-07-442392

Published: 2013

Includes: Supplemental data

Journal Articles

Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study

Roberto Raimondi, Alberto Tosetto, Rosi Oneto, Riccardo Cavazzina, Francesco Rodeghiero, Andrea Bacigalupo, Renato Fanin, Alessandro Rambaldi, Alberto Bosi

Blood (2012) 120 (6): 1327–1333.

https://doi.org/10.1182/blood-2012-03-414573

Published: 2012

Journal Articles

Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score

Alberto Tosetto, M.D., Alfonso Iorio, Maura Marcucci, Trevor Baglin, MD, Mary Cushman, MD, MSc, Sabine Eichinger, MD, Gualtiero Palareti, Daniela Poli, MD, Campbell R Tait, James D. Douketis, MD

Blood (2011) 118 (21): 544.

https://doi.org/10.1182/blood.V118.21.544.544

Published: 2011

Journal Articles

Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study

Benilde Cosmi, Cristina Legnani, Alberto Tosetto, Vittorio Pengo, Angelo Ghirarduzzi, Sophie Testa, Domenico Prisco, Daniela Poli, Armando Tripodi, Francesco Marongiu, Gualtiero Palareti, for the PROLONG Investigators (on behalf of Italian Federation of Anticoagulation Clinics)

Blood (2010) 115 (3): 481–488.

https://doi.org/10.1182/blood-2009-08-237354

Published: 2010

Journal Articles

How I treat von Willebrand disease

Francesco Rodeghiero, Giancarlo Castaman, Alberto Tosetto

Blood (2009) 114 (6): 1158–1165.

https://doi.org/10.1182/blood-2009-01-153296

Published: 2009

Journal Articles

A Poor Response to Desmopressin Is Observed in Patients with Mild Hemophilia a and No Detectable FVIII Mutation.

Giancarlo Castaman, Sofia Giacomelli, Elena Santagostino, Alberto Tosetto, MariaElisa Mancuso, Pier M. Mannucci, Francesco Rodeghiero

Blood (2008) 112 (11): 3383.

https://doi.org/10.1182/blood.V112.11.3383.3383

Published: 2008

Journal Articles

A Prospective Evaluation of Bleeding Tendency and Efficacy of Antihemorrhagic Treatments in Patients with Increased Von Willebrand Factor (VWF) Clearance (Von Willebrand Disease Vicenza AND C1130F Mutation).

Giancarlo Castaman, Alberto Tosetto, Augusto B. Federici, Francesco Rodeghiero

Blood (2008) 112 (11): 3385.

https://doi.org/10.1182/blood.V112.11.3385.3385

Published: 2008

NARROW

Lenalidomide Maintenance after VTD Induction and Autologous Stem Cell Transplantation: An Italian Real-Life Study of 558 Patients

Treatment of Portal, Mesenteric, and Splenic Vein Thrombosis with Rivaroxaban: A Pilot, Prospective Cohort Study

Risk of Recurrence after Stopping Anticoagulants in Women with Combined Oral Contraceptive-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis

A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

How I treat type 2 variant forms of von Willebrand disease

Safety of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study

D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study

Platelet Cut-Off For Anticoagulant Therapy In Cancer Patients With Venous Thromboembolism and Thrombocytopenia: An Expert Opinion Based On RAND/UCLA Appropriateness Method (RAM)

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study

Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score

Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study

How I treat von Willebrand disease

A Poor Response to Desmopressin Is Observed in Patients with Mild Hemophilia a and No Detectable FVIII Mutation.

A Prospective Evaluation of Bleeding Tendency and Efficacy of Antihemorrhagic Treatments in Patients with Increased Von Willebrand Factor (VWF) Clearance (Von Willebrand Disease Vicenza AND C1130F Mutation).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only